Вірменія - англійська - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

bayer schering pharma ag - gadopentetic acid (gadopentetate dimeglumine) - solution for injection - 469mg/ml

Мальта - англійська - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - gadopentate dimeglumine - solution for injection - gadopentate dimeglumine - contrast media

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

bayer new zealand limited - meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) - solution for injection - 469 mg/ml - active: meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) excipient: meglumine pentetic acid water for injection

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

bayer new zealand limited - meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) - solution for injection - 469 mg/ml - active: meglumine gadopentetate 469 mg/ml (formed from gadolinium oxide, diethylenetriamine pentetic acid & meglumine) excipient: meglumine pentetic acid water for injection - for diagnostic use by intravenous administration only. cranial and spinal magnetic resonance imaging (mri) in particular for the demonstration of tumours and for further differential-diagnostic clarification in suspected meningioma, (acoustic) neurinoma, invasive tumours (e.g. glioma) and metastases; for the demonstration of small and/or isointense tumours; in suspected recurrence after surgery or radiotherapy; for the differentiated demonstration of rare neoplasms such as haemangioblastomas, ependymomas and small pituitary adenomas; for improved determination of the spread of tumours not of cerebral origin. additionally in spinal mri: differentiation of intra- and extramedullary tumours; demonstration of solid tumour areas in known syrinx; determination of intramedullary tumour spread. whole body mri including the facial skull, the neck region, the thoracic and abdominal space, the female breast, the pelvis and the active and passive locomotive apparatus and imaging of vessels throughout the body. in particular, magnevist permits diagnostic information: · for the demonstration or exclusion of tumours, inflammation and vascular lesions; · for determination of the spread and demarcation of these lesions; · for the differentiation of the internal structure of lesions; · for assessment of the circulatory situation of normal and pathologically changed tissues; · for the differentiation of tumour and scar tissue after therapy; · for the recognition of recurrent prolapse of a disk after surgery. · for the semi-quantitative evaluation of the renal function combined with anatomical organ diagnosis.

Філіппіни - англійська - FDA (Food And Drug Administration)

sankem healthcare inc - gadopentetate dimeglumine - solution for injection iv - 469mg/ml

Саудівська Аравія - англійська - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

bayer pharma ag - gadopentetate dimeglumine - solution for injection - 469.01 mg

Філіппіни - англійська - FDA (Food And Drug Administration)

endure medical, inc.; distributor: endure medical, inc. - gadopentetate dimeglumine - solution for injection (iv) - 469 mg/ ml

Філіппіни - англійська - FDA (Food And Drug Administration)

s.m.h.p. marketing & consultancy; distributor: s.m.h.p. marketing & consultancy - gadopentetate dimeglumine - solution for injection (iv) - 469mg/ml

Танзанія - англійська - Tanzania Medicinces & Medical Devices Authority

unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd), india - gadopentetate dimeglumine - solution for injection - 20 ml

Танзанія - англійська - Tanzania Medicinces & Medical Devices Authority

unique pharmaceutical laboratories (a division of j.b. chemicals & pharmaceuticals ltd), india - gadopentetate dimeglumine - solution for injection - 287.469